Cryopyrin-associated periodic syndromes (CAPS) are caused by gain-of-function mutations of NLRP3, and blocking NLRP3 phosphorylation by S194A mutation abolishes LPS-induced CAPS-associated inflammasome activation [82]. This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.